source
- China clamps down on investigator-initiated biotech trials after patient deaths, halting rare-disease studiesChinese regulators have introduced new rules that sharply limit investigator‑initiated biotech trials after a series of patient deaths were reported this summer. The policy shift is intended to tig…
- PhRMA spent roughly $59 million on search ads to shape public views on drug pricingPhRMA, the trade group for U.S. drug makers, spent about $59 million on search advertising over a recent seven‑year period to influence how Americans perceive prescription‑drug costs. Roughly $32…